← Back to Search

Sleep Management for Nicotine Addiction

N/A
Recruiting
Led By Karen L Cropsey, Psy.D.
Research Sponsored by University of Alabama at Birmingham
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Daily smoker (5 or more cigarettes a day for the past one year and having smoked more than 100 cigarettes in lifetime) or non-smoker (smoked fewer than 100 cigarettes in a lifetime and no smoking-not even a puff- in the last year)
18 years or older
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 6 months
Awards & highlights

Summary

This trial will test the hypothesis that chronotype (preference for morning or evening activity) and impaired sleep impact cigarette usage, smoking dependence, urge/craving, and withdrawal differently in blacks compared to whites.

Who is the study for?
This trial is for adults over 18 who can read and speak English, identify as non-Hispanic African American or white, and live in Alabama. It's for daily smokers (5+ cigarettes a day for the past year) or non-smokers (less than 100 cigarettes lifetime, none in the last year).
What is being tested?
The study examines how sleep patterns affect cigarette cravings and withdrawal by comparing two conditions: extending participants' sleep time versus restricting it. The focus is on racial differences in these effects.
What are the potential side effects?
Since this trial involves manipulating sleep patterns, side effects may include tiredness, irritability, changes in mood or alertness due to altered sleep duration.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I am a daily smoker or I have never smoked more than 100 cigarettes in my life.
Select...
I am 18 years old or older.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~6 months
This trial's timeline: 3 weeks for screening, Varies for treatment, and 6 months for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Sleep Hygiene Index
Secondary outcome measures
Dysfunctional Beliefs and Attitudes About Sleep (DBAS)
Epworth Sleepiness Scale (ESS)
Everyday Discrimination Scale (EDS)
+6 more
Other outcome measures
Alcohol Use Disorders Identification Test-Concise (AUDIT-C).
Assessing Smoking History
Brief Wisconsin Inventory of Smoking Dependence Motives (WISDM-37)
+14 more

Trial Design

2Treatment groups
Experimental Treatment
Group I: Sleep RestrictionExperimental Treatment1 Intervention
4 hours time in bed (1 am to 5 am)
Group II: Sleep ExtensionExperimental Treatment1 Intervention
10 hours time in bed (10 pm to 8 am)

Find a Location

Who is running the clinical trial?

National Institute on Drug Abuse (NIDA)NIH
2,543 Previous Clinical Trials
3,249,326 Total Patients Enrolled
15 Trials studying Nicotine Addiction
2,106 Patients Enrolled for Nicotine Addiction
University of OklahomaOTHER
464 Previous Clinical Trials
91,083 Total Patients Enrolled
University of Alabama at BirminghamLead Sponsor
1,621 Previous Clinical Trials
2,290,928 Total Patients Enrolled

Media Library

Sleep restriction condition Clinical Trial Eligibility Overview. Trial Name: NCT03968900 — N/A
Nicotine Addiction Research Study Groups: Sleep Restriction, Sleep Extension
Nicotine Addiction Clinical Trial 2023: Sleep restriction condition Highlights & Side Effects. Trial Name: NCT03968900 — N/A
Sleep restriction condition 2023 Treatment Timeline for Medical Study. Trial Name: NCT03968900 — N/A
Nicotine Addiction Patient Testimony for trial: Trial Name: NCT03968900 — N/A
~5 spots leftby Mar 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top